We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$413M
AUM Growth
-$3.2M
Cap. Flow
-$7.27M
Cap. Flow %
-1.76%
Top 10 Hldgs %
30.14%
Holding
1,129
New
83
Increased
245
Reduced
309
Closed
247

Top Buys

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$21.4M
2
STLA icon
Stellantis
STLA
+$18M
3
CNH
CNH Industrial
CNH
+$11.6M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.3M
5
IVE icon
iShares S&P 500 Value ETF
IVE
+$6.71M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$23.5M
2
LIN icon
Linde
LIN
+$8.45M
3
V icon
Visa
V
+$5.42M
4
ALC icon
Alcon
ALC
+$3.14M
5
TMUS icon
T-Mobile US
TMUS
+$3.04M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.6%
2 Technology 15.31%
3 Miscellaneous 15.03%
4 Industrials 9.82%
5 Financials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DT icon
676
Dynatrace
DT
$16B
$1.63K ﹤0.01%
27
-1,281
-98% -$87.3K
ILF icon
677
iShares Latin America 40 ETF
ILF
$3.87B
$1.59K ﹤0.01%
68
– –
CSGP icon
678
CoStar Group
CSGP
$12.3B
$1.58K ﹤0.01%
20
– –
CLR
679
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$1.52K ﹤0.01%
34
– –
AVTR icon
680
Avantor
AVTR
$10.6B
$1.52K ﹤0.01%
36
– –
CRSP icon
681
CRISPR Therapeutics
CRSP
$5.05B
$1.52K ﹤0.01%
20
-900
-98% -$78.6K
CGAU
682
Centerra Gold
CGAU
$4.29B
$1.43K ﹤0.01%
186
– –
RACE icon
683
PUT
Ferrari
RACE
$72.4B
$1.42K ﹤0.01%
3
-212
-99% -$52.2K
IGMS
684
DELISTED
IGM Biosciences
IGMS
$1.41K ﹤0.01%
48
– –
XME icon
685
State Street SPDR S&P Metals & Mining ETF
XME
$4.45B
$1.39K ﹤0.01%
31
– –
HES
686
DELISTED
Hess
HES
$1.33K ﹤0.01%
18
– –
CTAS icon
687
Cintas
CTAS
$79.8B
$1.33K ﹤0.01%
12
– –
REZI icon
688
Resideo Technologies
REZI
$2.83B
$1.3K ﹤0.01%
50
– –
FAST icon
689
Fastenal
FAST
$56.3B
$1.28K ﹤0.01%
40
– –
CSX icon
690
CSX Corp
CSX
$88.7B
$1.24K ﹤0.01%
33
– –
BURL icon
691
Burlington
BURL
$14.5B
$1.17K ﹤0.01%
4
– –
ANIP icon
692
ANI Pharmaceuticals
ANIP
$1.69B
$1.15K ﹤0.01%
25
– –
SLG icon
693
SL Green Realty
SLG
$3.67B
$1.15K ﹤0.01%
16
– –
AXSM icon
694
Axsome Therapeutics
AXSM
$11.1B
$1.13K ﹤0.01%
30
– –
DPZ icon
695
Domino's
DPZ
$9.97B
$1.13K ﹤0.01%
2
– –
ARGT icon
696
Global X MSCI Argentina ETF
ARGT
$793M
$1.13K ﹤0.01%
36
– –
GT icon
697
Goodyear
GT
$1.49B
$1.11K ﹤0.01%
52
– –
KSA icon
698
iShares MSCI Saudi Arabia ETF
KSA
$614M
$1.1K ﹤0.01%
27
– –
INDA icon
699
iShares MSCI India ETF
INDA
$6.44B
$1.1K ﹤0.01%
24
– –
MSI icon
700
Motorola Solutions
MSI
$76.2B
$1.09K ﹤0.01%
4
– –
26 27
28
29 30

Similar funds

PC
Plaisance Capital Denver, Colorado $172M AUM 27.11% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LPWM
Lake Point Wealth Management Rockwall, Texas $176M AUM 11.87% 1-Year Est. Return
ACM
Aquamarine Capital Management New York $170M AUM 15.49% 1-Year Est. Return
HWIS
Hancock Whitney Investment Services New Orleans, Louisiana $157M AUM
LWM
Loveless Wealth Management Billings, Montana $153M AUM 3.63% 1-Year Est. Return
EW
Emerson Wealth Bloomfield Hills, Michigan $153M AUM 16.38% 1-Year Est. Return
GDWAM
Gold Dragon Worldwide Asset Management Central, Hong Kong $151M AUM 54.24% 1-Year Est. Return

Exane Derivatives's Q4 2021 Portfolio in Review

As of Q4 2021, Exane Derivatives held 1,129 positions worth $413M, down 0.77% from $417M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Exane Derivatives's Q4 2021 filing shows 83 new, 245 increased, 309 reduced and 247 closed positions. Its largest new stake was EngageSmart, Inc.: 45,605 shares worth $1.1M. The largest sale was UBS Group, an estimated $23.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 11% a quarter earlier, followed by Technology and Miscellaneous.

  • Exane Derivatives's largest Q4 2021 buy was EngageSmart, Inc.: 45,605 shares worth $1.1M.
  • Exane Derivatives added most to Ferrari in Q4 2021, an estimated $21.4M increase.
  • Exane Derivatives's biggest Q4 2021 reduction was UBS Group, cutting an estimated $23.5M.
  • Exane Derivatives fully exited Visa in Q4 2021, selling an estimated $5.42M.
  • Exane Derivatives's ten largest holdings make up 30% of its $413M portfolio in Q4 2021.
  • Exane Derivatives opened 83 new positions and closed 247 in Q4 2021.
  • Exane Derivatives's portfolio value fell 0.77% quarter-over-quarter to $413M.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.